1. Risks of ACE Inhibitor and ARB Usage in COVID‐19: Evaluating the Evidence
   Krishna Sriram et al, 2020, Clinical Pharmacology & Therapeutics CrossRef
2. Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
   Simon B. Gressens et al, 2021, Frontiers in Physiology CrossRef
3. Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models
   Andrea Baehr et al, 2019, International Journal of Molecular Sciences CrossRef
4. ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?
   Pasquale Pagliaro et al, 2020, Frontiers in Medicine CrossRef
5. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature
   Laurence W. Busse et al, 2017, Critical Care CrossRef
6. Extracorporeal membrane oxygenation mitigates myocardial injury and improves survival in porcine model of ventricular fibrillation cardiac arrest
   Bo Liu et al, 2019, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine CrossRef
7. Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review
   Hajira Dambha-Miller et al, 2020, BMJ Open CrossRef
8. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
   Murat Oz et al, 2021, Pharmacology & Therapeutics CrossRef
9. Sex‐related differences in COVID‐19 lethality
   Claudia Penna et al, 2020, British Journal of Pharmacology CrossRef